HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Open accessThe DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells (MDSCs) are a major component of the immune-suppressive network described in cancer and many other pathological conditions. We demonstrate that although MDSCs from peripheral lymphoid organs and the tumor site share similar phenotype and morphology, these cells display profound functional differences. MDSC from peripheral lymphoid organs suppressed antigen-specific CD8+ T cells but failed to inhibit nonspecific T cell function. In sharp contrast, tumor MDSC suppressed both antigen-specific and nonspecific T cell activity. The tumor microenvironment caused rapid and dramatic up-regulation of arginase I and inducible nitric oxide synthase in MDSC, which was accompanied by down-regulation of nicotinamide adenine dinucleotide phosphate–oxidase and reactive oxygen species in these cells. In contrast to MDSC from the spleen, MDSC from the tumor site rapidly differentiated into macrophages. Exposure of spleen MDSC to hypoxia resulted in the conversion of these cells to nonspecific suppressors and their preferential differentiation to macrophages. Hypoxia-inducible factor (HIF) 1α was found to be primarily responsible for the observed effects of the tumor microenvironment on MDSC differentiation and function. Thus, hypoxia via HIF-1α dramatically alters the function of MDSC in the tumor microenvironment and redirects their differentiation toward tumor-associated macrophages, hence providing a mechanistic link between different myeloid suppressive cells in the tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypoxia can abolish the cell killing activity of NK cells, which correlates with an increase in HIF-1α [78].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“tumor hypoxia generates macrophages that can suppress T cell responses. This suppressive phenotype is mediated by hypoxic induction of arginase 1 and nitric oxide synthase, both that restrict T cell activation. Strikingly, induction of this hypoxic pathway in macrophages is required for optimal tumor growth [84, 85].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [85]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the mesothelioma microenvironment, the availability of glucose is critical, and competition for this molecule impacts on T-cell function and the recruitment of immune infiltrating cells, promoting angiogenesis [119,120,121,122].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [119]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, tumor hypoxia and/or HIFs can attract myeloid-derived suppressor cells (Corzo et al., 2010), regulatory T-cells (Clambey et al., 2012), and tumor-associated macrophages (Doedens et al., 2010;Imtiyaz et al., 2010) with immunosuppressive functions.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Corzo et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which suggests that 32-134D inhibited the expression of these latter mRNAs in immune or other stromal cell types, where HIFs are known to play critical roles (56–61), rather than in tumor cells.”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [56]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · cited 2×
“Extensive studies in recent years suggested several mechanisms of MDSC-mediated immune suppression that involve arginine (Bronte and Zanovello, 2005; Rodríguez and Ochoa, 2008) and cysteine (Srivastava et al., 2010) metabolism, expression of some surface molecules (Pan et al., 2010), up-regulation…”
BackgroundMyeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Self-citationSubsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Self-citationAlmand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Self-citationMovahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Cited by
Items 601–700 of 1,000
Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 39
Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis
Liu, W., Wang, B., Zhou, M., Liu, D., Chen, F., Zhao, X., & Lu, Y. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0272 · Cited by 42
Tesone, A. J., Svoronos, N., Allegrezza, M. J., & Conejo-Garcia, J. R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00435 · Cited by 36
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Engel, C., Brügmann, G., Lambing, S., Mühlenbeck, L. H., Marx, S., Hagen, C., Horváth, D., Goldeck, M., Ludwig, J., Herzner, A., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0129-t · Cited by 35
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis
Lee, S. F., Ng, T. Y., & Spika, D. (2019) · BMC Cancer · doi:10.1186/s12885-019-5552-1 · Cited by 33
Liu, X., Duan, L., Chen, Y., Jin, X., Zhu, N., Zhou, X., Wei, H., Yin, L., & Guo, J. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.020 · Cited by 34
RetractedAblation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
Papafragkos, I., Grigoriou, M., Boon, L., Kloetgen, A., Hatzioannou, A., & Verginis, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889075 · Cited by 34
Ianni, N. D., Musio, S., & Pellegatta, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094460 · Cited by 36
Metabolism in tumor-associated macrophages
Li, J., DeNicola, G. M., & Ruffell, B. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.01.004 · Cited by 39
MDSC: a new potential breakthrough in CAR-T therapy for solid tumors
Abdalsalam, N. M. F., Ibrahim, A., Saliu, M. A., Liu, T., Wan, X., & Yan, D. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01995-y · Cited by 41
Liu, D., Liu, L., Zhao, X., Zhang, X., Chen, X., Che, X., & Wu, G. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104702 · Cited by 43
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer
Aliper, A. M., Korovkina, V. P., Buzdin, A. A., Roumiantsev, S. A., & Zhavoronkov, A. A. (2014) · Oncotarget · doi:10.18632/oncotarget.2489 · Cited by 35
Environmental factors in breast cancer invasion: a mathematical modelling review
Simmons, A., Burrage, P., Nicolau, D. V., Lakhani, S. R., & Burrage, K. (2017) · Pathology · doi:10.1016/j.pathol.2016.11.004 · Cited by 35
Insights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing
Ponomarev, А. V., & Shubina, I. Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01115 · Cited by 40
Contribution of Macrophages and T Cells in Skeletal Metastasis
Mendoza‐Reinoso, V., McCauley, L. K., & Fournier, P. G. J. (2020) · Cancers · doi:10.3390/cancers12041014 · Cited by 37
Cao, R., Ma, B., Wang, G., Xiong, Y., Tian, Y., & Yuan, L. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.06.011 · Cited by 37
Immunometabolism modulation, a new trick of edible and medicinal plants in cancer treatment
Tan, W., Pan, T., Wang, S., Li, P., Men, Y., Tan, R., Zhong, Z., & Wang, Y. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.131860 · Cited by 39
Targeting amino acid-metabolizing enzymes for cancer immunotherapy
Grobben, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440269 · Cited by 38
Hu, T., Zhai, J., Yang, Z., Peng, J., Wang, C., Liu, X., Li, Y., Yao, J., Chen, F., Li, H., et al. (2025) · MedComm · doi:10.1002/mco2.70231 · Cited by 40
Role of Myeloid-Derived Suppressor Cells in Tumor Immunotherapy
Martin, F., Apétoh, L., & Ghiringhelli, F. (2011) · Immunotherapy · doi:10.2217/imt.11.154 · Cited by 35
Differential Regulation of Myeloid-Derived Suppressor Cells by Candida Species
Singh, A., Lelis, F., Braig, S., Schäfer, I., Hartl, D., & Rieber, N. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01624 · Cited by 33
Vescovi, R., Monti, M., Moratto, D., Paolini, L., Consoli, F., Gatta, L. B., Melocchi, L., Calza, S., Chiudinelli, M., Rossi, G., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0141 · Cited by 32
Adenosine Signaling in the Tumor Microenvironment
Antonioli, L., Fornai, M., Pellegrini, C., D’Antongiovanni, V., Turiello, R., Morello, S., Haskó, G., & Blandizzi, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_9 · Cited by 33
HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases
Li, R., He, L., Zhang, Q. H., Liu, J., Lü, F., Duan, H., Fan, L., Peng, W., Huang, Y., & Wu, C. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s274980 · Cited by 37
Xiao, M., Shi, Y., Jiang, S., Cao, M., Chen, W., Xu, Y. F., Xu, Z., & Wang, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1039378 · Cited by 37
Yan, J., Tingey, C., Lyde, R. B., Gorham, T., Choo, D. K., Muthumani, A., Myles, D. J. F., Weiner, L. P., Kraynyak, K. A., Reuschel, E. L., et al. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.56 · Cited by 31
Cubillos-Zapata, C., Hernández-Jiménez, E., Avendaño-Ortiz, J., Toledano, V., Varela-Serrano, A., Fernández-Navarro, I., Casitas, R., Carpio, C., Aguirre, L. A., García-Río, F., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/7373921 · Cited by 31
Glutamate blunts cell‐killing effects of neutrophils in tumor microenvironment
Xiong, T., He, P., Zhou, M., Zhong, D., Yang, T., He, W., Xu, Z., Chen, Z., Liu, Y., & Dai, S. (2022) · Cancer Science · doi:10.1111/cas.15355 · Cited by 32
Immune consequences of exercise in hypoxia: A narrative review
Burtscher, J., Pasha, Q., Chanana, N., Millet, G. P., Burtscher, M., & Strasser, B. (2023) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2023.09.007 · Cited by 35
Zhang, T., Lv, Q., & Jin, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189137 · Cited by 44
Yang, L., Hu, Q., & Huang, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137208 · Cited by 35
The Mononuclear Phagocyte System in Organ Transplantation
Ochando, J., Kwan, W.-H., Ginhoux, F., Hutchinson, J. A., Hashimoto, D., & Collin, M. P. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13627 · Cited by 33
Sceneay, J., Griessinger, C. M., Hoffmann, S. H. L., Wen, S., Wong, C. S. F., Krumeich, S., Kneilling, M., Pichler, B. J., & Möller, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196040 · Cited by 33
Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer
Jayakumar, A., & Bothwell, A. L. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900500 · Cited by 32
Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
Palumbo, G. A., Parrinello, N. L., Giallongo, C., D’Amico, E., Zanghì, A., Puglisi, F., Conticello, C., Chiarenza, A., Tibullo, D., Raimondo, F. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215459 · Cited by 34
Waldenmaier, M., Seibold, T., Seufferlein, T. T. W., & Eiseler, T. (2021) · Cancers · doi:10.3390/cancers13194844 · Cited by 33
Drafting the proteome landscape of myeloid‐derived suppressor cells
Gato, M., Blanco‐Luquin, I., Zudaire, M., de Morentin, X. M., Pérez‐Valderrama, E., Zabaleta, A., Kochan, G. T., Escors, D., Fernández‐Irigoyen, J., & Santamaría, E. (2015) · PROTEOMICS · doi:10.1002/pmic.201500229 · Cited by 34
Lim, H. X., Choi, S., Cho, D., & Kim, T. S. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.72 · Cited by 31
In Vitro Modeling of Tumor–Immune System Interaction
Mengus, C., Muraro, M. G., Mele, V., Amicarella, F., Manfredonia, C., Foglietta, F., Muenst, S. E., Soysal, S. D., Iezzi, G., & Spagnoli, G. C. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00077 · Cited by 34
Immune regulation and anti-cancer activity by lipid inflammatory mediators
Khadge, S., Sharp, J. G., McGuire, T. R., Thiele, G. M., Black, P. N., Dirusso, C., Cook, L. M., Klassen, L. W., & Talmadge, J. E. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.026 · Cited by 35
Zeng, D., Wang, M., Wu, J., Lin, S., Ye, Z., Zhou, R., Wang, G., Wu, J., Sun, H., Bin, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.620688 · Cited by 34
Jones, M. G., Sun, D., Min, K. H., Colgan, W. N., Wang, H., Torok, T., Ribeiro, J., Xue, J., Cardoso, E. C., Rong, Y., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02739-z · Cited by 42
Sumida, K., Ohno, Y., Ohtake, J., Kaneumi, S., Kishikawa, T., Takahashi, N., Taketomi, A., & Kitamura, H. (2015) · Scientific Reports · doi:10.1038/srep13650 · Cited by 30
Impaired Neovascularization in Aging
Bonham, C. A., Kuehlmann, B. A., & Gurtner, G. C. (2019) · Advances in Wound Care · doi:10.1089/wound.2018.0912 · Cited by 34
Caveolin‐1 in oncogenic metabolic symbiosis
Raudenská, M., Gumulec, J., Balvan, J., & Masařík, M. (2020) · International Journal of Cancer · doi:10.1002/ijc.32987 · Cited by 33
Glioblastoma microenvironment: The stromal interactions
Uyar, R. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153813 · Cited by 39
Shen, X. Z., Okwan-Duodu, D. K., Blackwell, W.-L. B., Ong, F. S.-C., Janjulia, T., Bernstein, E. A., Fuchs, S., Alkan, S., & Bernstein, K. E. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.41 · Cited by 30
Li, Y.-R., Ochoa, C. J., Zhu, Y., Kramer, A. B., Wilson, M., Fang, Y., Chen, Y., Singh, T., DiBernardo, G., Zhu, E., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107952 · Cited by 35
Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment
Han, X., Song, X., Xiao, Z., Zhu, G., Gao, R., Ni, B., & Li, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1310442 · Cited by 33
CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma
Stahl, D. J., Gödel, P., Balke‐Want, H., Gholamipoorfard, R., Segbers, P., Tetenborg, L., Koker, M., Dörr, J., Gregor, L., Bachurski, D., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.013 · Cited by 44
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
DiGiacomo, J. W., & Gilkes, D. M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0555-4 · Cited by 31
Zhang, D., Xu, J., Ren, J., Ding, L., Shi, G., Li, D., Dou, H., & Hou, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01443 · Cited by 29
Sun, H.-W., Chen, J., Wu, W., Yang, Y., Xu, Y.-T., Yu, X.-J., Chen, H., Wang, Z., Wu, X., & Zheng, L. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0389 · Cited by 30
Garofalo, C., Marco, C. D., & Cristiani, C. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754541 · Cited by 32
The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer
García‐Estévez, L., González-Martínez, S., & Moreno‐Bueno, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.784823 · Cited by 37
Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy
Li, J., Bolyard, C. M., Xin, G., & Li, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.747863 · Cited by 32
Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis
Wu, T., Wang, C., Wang, W., Hui, Y., Zhang, R., Qiao, L., & Dai, Y. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1498437 · Cited by 29
The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
Sieow, J. L., Gun, S. Y., & Wong, S. C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00168 · Cited by 30
HDACi delivery reprograms tumor-infiltrating myeloid cells to eliminate antigen-loss variants
Nguyen, A., Ho, L., Workenhe, S. T., Chen, L., Samson, J., Walsh, S. R., Pol, J., Bramson, J. L., & Wan, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.040 · Cited by 29
Role of Hypoxia in the Interferon Response
Arnaiz, E., & Harris, A. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821816 · Cited by 30
Shafqat, A., Omer, M. H., Ahmed, E. N., Mushtaq, A. H., Ijaz, E., Ahmed, Z., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200941 · Cited by 36
Metabolic reprogramming of neutrophils in the tumor microenvironment: Emerging therapeutic targets
Huang, S., Shi, J., Shen, J., & Fan, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217466 · Cited by 35
Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch
Aki, D., Li, Q., Li, H., Liu, Y., & Lee, J. H. (2018) · Protein & Cell · doi:10.1007/s13238-018-0586-8 · Cited by 29
Zhang, X., Chen, D.-G., Li, S. C., Zhu, B., & Li, Z. (2021) · Cells · doi:10.3390/cells10040903 · Cited by 32
Gross, D., Chintala, N. K., Vaghjiani, R. G., Grosser, R. A., Tan, K. S., Li, X., Choe, J. K., Li, Y., Aly, R. G. M., Emoto, K., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.09.009 · Cited by 34
Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
Lin, H.-J. L., Liu, Y., Lofland, D., & Lin, J. (2022) · Cancers · doi:10.3390/cancers14020285 · Cited by 31
Functional significance of mononuclear phagocyte populations generated through adult hematopoiesis
Gutknecht, M. F., & Bouton, A. H. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ri0414-195r · Cited by 32
Goswami, K. K., Sarkar, M., Ghosh, S., Saha, A., Ghosh, T., Guha, I., Barik, S., Banerjee, S., Roy, S., Bose, A., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.008 · Cited by 31
Myeloid-derived suppressor cells and their role in gynecological malignancies
Mabuchi, S., Yokoi, E., Komura, N., & Kimura, T. (2018) · Tumor Biology · doi:10.1177/1010428318776485 · Cited by 29
Sieow, J. L., Penny, H. L., Gun, S. Y., Tan, L. Q., Duan, K., Yeong, J. P. S., Pang, A., Lim, D., Toh, H. C., Lim, T. K. H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010753 · Cited by 27
Glioma–Immune Cell Crosstalk in Tumor Progression
Elguindy, M. M., Young, J. S., Mondal, I., Lu, R. O., & Ho, W. S. (2024) · Cancers · doi:10.3390/cancers16020308 · Cited by 35
Wu, H., Li, J., Yao, R., Liu, J., Su, L., & You, W. (2025) · Theranostics · doi:10.7150/thno.113727 · Cited by 36
Shi, S., Chen, L., & Huang, G. (2013) · Medical Oncology · doi:10.1007/s12032-013-0698-1 · Cited by 31
Macrophage NOS2 in Tumor Leukocytes
Brüne, B., Courtial, N., Dehne, N., Syed, S. N., & Weigert, A. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6811 · Cited by 30
Protocol to assess the suppression of T-cell proliferation by human MDSC
Bruger, A. M., Vanhaver, C., Bruderek, K., Amodio, G., Tavukçuoğlu, E., Esendağlı, G., Gregori, S., Brandau, S., & van der Bruggen, P. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.05.046 · Cited by 28
Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced Cancer
Ostrand‐Rosenberg, S. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042120-105240 · Cited by 27
Suszczyk, D., Skiba, W., Jakubowicz-Gil, J., Kotarski, J., & Wertel, I. (2021) · Cells · doi:10.3390/cells10030677 · Cited by 30
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
Frosch, J., Leontari, I., & Anderson, J. (2021) · Cancers · doi:10.3390/cancers13071743 · Cited by 29
Nanotechnology Applications in Breast Cancer Immunotherapy
Wang, R., Kumar, P., Reda, M. M., Wallstrum, A., Crumrine, N. A., Ngamcherdtrakul, W., & Yantasee, W. (2023) · Small · doi:10.1002/smll.202308639 · Cited by 36
Chen, X., Zhang, Z., Bi, Y., Fu, Z., Gong, P., Li, Y., Yu, Q., Jia, A., Wang, J., Xue, L., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a1115-492r · Cited by 27
Kotzé, L. A., Young, C., Leukes, V., John, V., Fang, Z., Walzl, G., Lutz, M. B., & du Plessis, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102670 · Cited by 28
Wu, S., Anand, N., Guo, Z., Li, M., Figueroa, M. S., Jung, L., Kelly, S., & Franses, J. W. (2025) · Cancers · doi:10.3390/cancers17111860 · Cited by 31
Leung, J., & Suh, W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201242 · Cited by 30
Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
Plavc, G., Jesenko, T., Oražem, M., & Strojan, P. (2020) · Cancers · doi:10.3390/cancers12113197 · Cited by 29
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Mojsilović, S. B., Mojsilović, S. S., Bjelica, S., & Santibanez, J. F. (2021) · Developmental Dynamics · doi:10.1002/dvdy.339 · Cited by 28
Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Liang, L., Xu, X., Li, J., & Yang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883683 · Cited by 26
NK Cells Under Hypoxia: The Two Faces of Vascularization in Tumor and Pregnancy
Garces, I., Kotzur, R., Cerwenka, A., & Mandelboim, O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.924775 · Cited by 33
Falck‐Jones, S., Österberg, B., & Smed‐Sörensen, A. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13559 · Cited by 29
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Cannito, S., Dianzani, U., Parola, M., Albano, E., & Sutti, S. (2023) · Bioscience Reports · doi:10.1042/bsr20221271 · Cited by 31
Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages
Cannon, M. J., Ghosh, D., & Gujja, S. (2015) · Vaccines · doi:10.3390/vaccines3020448 · Cited by 29
Su, N. Y., Yue, Y., & Xiong, S. (2016) · Scientific Reports · doi:10.1038/srep22658 · Cited by 27
Li, C., Liu, T., Bazhin, A. V., & Yang, Y. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25726 · Cited by 29
Yu, Z., Wang, B., & Cheng, Z. (2017) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2017.05.014 · Cited by 25
Hsieh, C., Lin, C., He, J.-T., Chiang, M., Wang, Y., Tsai, Y.-C., Hung, C., & Chang, P. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0915-0 · Cited by 27
Liu, Y., Zhuang, K., Chen, B., Li, P., Zhou, X., Jiang, H., Zhong, L., & Liu, F. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1654-4 · Cited by 26
Dong, Y., Zhang, S., Gao, X., Yin, D., Wang, T., Li, Z., Wan, Z., Wei, M., Luo, Y., Yang, G., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.008 · Cited by 39
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Liu, X., Kang, X., Kang, H., & Yan, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02170-7 · Cited by 33
Tasquinimod targets suppressive myeloid cells in the tumor microenvironment
Shen, L., & Пили, Р. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1072672 · Cited by 25
Immune System Efficiency in Cancer and the Microbiota Influence
Barbosa, A. M., Gomes-Gonçalves, A., Castro, A. G., & Torrado, E. (2021) · Pathobiology · doi:10.1159/000512326 · Cited by 26
Zefferino, R., Piccoli, C., Gioia, S. D., Capitanio, N., & Conese, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052550 · Cited by 29
Metadata
- Authors
- Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., & Gabrilovich, D. I.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Gabrilovich, Dmitry I.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-09-27
- Volume
- 207
- Issue
- 11
- Pages
- 2439-2453
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2964584
- OpenAlex
- W2109424201
- Semantic Scholar
- 77cf3cf3976e026979d2b7acf9b04119740a45f1
- Cited by
- 1,173
- References
- 56
- Citations by year
- 2026: 69 · 2025: 73 · 2024: 69 · 2023: 92 · 2022: 80 · 2021: 109 · 2020: 93 · 2019: 62 · 2018: 83 · 2017: 62 · 2016: 69 · 2015: 51 · 2014: 70 · 2013: 76 · 2012: 61
- FWCI
- 25.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Moffitt Cancer Center
- National Institutes of Health
- National Cancer Institute (CA84488, R01CA084488, R01CA103921, R01CA136828, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- myeloid-derived suppressor cells, HIF-1α, tumor microenvironment, hypoxia, tumor-associated macrophages, T cell suppression, arginase-1, inducible nitric oxide synthase, NADPH oxidase, reactive oxygen species, MDSC differentiation, immunosuppression
- MeSH terms
- Aged, Animals, Antigens, Neoplasm, Arginase, Cell Differentiation, Female, Humans, Macrophages, Male, Mice, Inbred BALB C, Middle Aged, Neoplasms, Cell Hypoxia, CD8-Positive T-Lymphocytes, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.